Evidence map›Paper›PMID 33570182›Full record

Trial reportBritish journal of haematology2021

Cognitive performance as a predictor of healthcare transition in sickle cell disease.

Anjelica C Saulsberry-Abate, Marita Partanen, Jerlym S Porter, Pradeep S B Podila, Jason R Hodges, Allison A King, Winfred C Wang, Jane E Schreiber, Xiwen Zhao, Guolian Kang and 2 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in British journal of haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Anjelica C Saulsberry-AbateDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-4042-7853
Marita PartanenPrincess Maxima Center for Pediatric Oncology, Heidelberglaan, The Netherlands.
Jerlym S PorterDepartment of Psychology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Pradeep S B PodilaMethodist Comprehensive Sickle Cell Center, Methodist University Hospital, Memphis, TN, USA.
Jason R HodgesDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Allison A KingProgram in Occupational Therapy and Departments of Pediatrics and Medicine, Washington University, St. Louis, MO, USA.
Winfred C WangDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jane E SchreiberDepartment of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Xiwen ZhaoDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Guolian KangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Lisa M JacolaDepartment of Psychology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-2698-5816
Jane S HankinsDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-4439-7321
St. Jude Children's Research Hospital · USChildren's Hospital of Philadelphia · USMethodist University Hospital · USPrincess Máxima Center · NLWashington University in St. Louis · US

Funding

The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults with Sickle Cell Disease: From Clinic to the Community and BackU01HL133994 · NHLBI · WASHINGTON UNIVERSITY · PI KING, ALLISON A · 2016 to 2021
$5.2M
RE-aiming at Hydroxyurea Adherence for Sickle cell with mHealth (RE-HASH)U01HL133996 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HANKINS, JANE SILVA, KLESGES, LISA M · 2016 to 2021
$4.6M
Identification of Predictors and Outcomes of Sickle Cell Health Care TransitionK01HL125495 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PORTER, JERLYM S · 2016 to 2020
$767k
American Lebanese Syrian Associated CharitiesAmerican Society of HematologyLINKS Foundation Inc.NHLBI NIH HHS K01 HL125495NHLBI NIH HHS U01 HL133994NHLBI NIH HHS U01 HL133996
6 · The paper itself

Abstract

Neurocognitive deficits in sickle cell disease (SCD) may impair adult care engagement. We investigated the relationship between neurocognitive functioning and socio-environmental factors with healthcare transition outcomes. Adolescents aged 15-18 years who had neurocognitive testing and completed a visit with an adult provider were included. Transition outcomes included transfer interval from paediatric to adult care and retention in adult care at 12 and 24 months. Eighty adolescents (59% male, 64% HbSS/HbSβ

Indexed as

CognitionTransition to Adult CareAdolescentAnemia, Sickle CellFemaleHumansMaleMental Status and Dementia Testshealth literacyneurocognitionsickle cell diseasesilent infarctssocio-determinants of healthtransition to adult care

Identifiers

PMID33570182
PMCPMC8092972
OpenAlexW3128391731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.